Kon Zachary N, Kwon Michael H, Collins Michael J, Kallam Seeta, Sangrampurkar Rupali, Ozeki Toshinaga, Brown Emile N, Romar Linda G, Pierson Richard N, Gammie James S, Brown James M, Griffith Bartley P, Poston Robert S
Division of Cardiac Surgery, Department of Surgery, University of Maryland Medical System, Baltimore MD.
Innovations (Phila). 2006;1(5):232-238. doi: 10.1097/01.imi.0000242160.21278.b7.
It is believed that off-pump coronary artery bypass grafting (OPCAB) leads to hypercoagulability, but efforts to document such a state have been unrevealing. We hypothesized that OPCAB increases the risk of developing a regional hypercoagulable state. METHODS: Blood was obtained from the aorta and coronary sinus (CS) after CABG performed off- (N=69) or on-pump (N=35) to determine the transcardiac gradients of F1.2 (thrombin production), XIIa (coagulation activation), myoglobin (ischemia) and IL-6, IL-8 using ELISA and platelet-derived microparticles using FACS. Platelet function was measured using aggregometry. Regional myocardial pH and SVG flow were recorded intraoperatively. SVG biopsies were analyzed for endothelial integrity (EI) using immunohistochemistry and graft patency was determined by predischarge CT angiography. RESULTS: Compared with on-pump, OPCAB provoked significantly higher transcardiac F1.2 (117±200 v. 31±38%), FXII-a (14±29 v. 2±4%), microparticles (14±-9.5% v. 6.4±-4.1%), IL-6 (119±183 v. 28±39%), and a trend toward increased IL-8 (67±94 v. 24±46%, P = 0.077). Myoglobin release after OPCAB, also greater than on-pump CABG (54±89 v. 8±14%, P < 0.01), correlated with regional pH change (R=-0.96, P < 0.0001), and F1.2 release (R=0.55, P = 0.0002). In contrast, systemic changes in these markers were all less after OPCAB. SVG flow was significantly reduced in OPCAB (39.4 versus 66.5 mL/min, P = 0.0002), but EI and graft patency rates were the same. CONCLUSIONS: Through the use of transcardiac assays, we illustrated that regional coagulation was enhanced after off- compared with on-pump CABG. If the findings of this pilot study are confirmed, OPCAB may require additional antithrombotic therapies to respond to this local hypercoagulable state.
人们认为非体外循环冠状动脉旁路移植术(OPCAB)会导致高凝状态,但记录这种状态的努力一直没有结果。我们假设OPCAB会增加发生局部高凝状态的风险。方法:在非体外循环(N = 69)或体外循环(N = 35)冠状动脉旁路移植术后,从主动脉和冠状窦(CS)采集血液,使用酶联免疫吸附测定法(ELISA)测定F1.2(凝血酶生成)、XIIa(凝血激活)、肌红蛋白(缺血)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)的跨心脏梯度,使用荧光激活细胞分选术(FACS)测定血小板衍生微粒。使用凝集测定法测量血小板功能。术中记录局部心肌pH值和大隐静脉桥血流量。使用免疫组织化学分析大隐静脉桥活检组织的内皮完整性(EI),并通过出院前CT血管造影确定移植物通畅情况。结果:与体外循环相比,OPCAB引起的跨心脏F1.2(117±200对31±38%)、FXII-a(14±29对2±4%)、微粒(14± - 9.5%对6.4± - 4.1%)、IL-6(119±183对28±39%)显著更高,IL-8有升高趋势(67±94对24±46%,P = 0.077)。OPCAB后的肌红蛋白释放也高于体外循环冠状动脉旁路移植术(54±89对8±14%,P < 0.01),与局部pH值变化相关(R = - 0.96,P < 0.0001),与F1.2释放相关(R = 0.55,P = 0.0002)。相比之下,OPCAB后这些标志物的全身变化均较小。OPCAB中的大隐静脉桥血流量显著降低(39.4对66.5 mL/分钟),但EI和移植物通畅率相同。结论:通过使用跨心脏检测方法,我们表明与体外循环冠状动脉旁路移植术相比,非体外循环后局部凝血增强。如果这项初步研究的结果得到证实,OPCAB可能需要额外的抗血栓治疗来应对这种局部高凝状态。